Wuhan Hiteck Biological Overview
Status
Public
Employees
762
Stock Symbol
300683
Share Price
$7.30
(As of Thursday Closing)
Wuhan Hiteck Biological General Information
Description
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Contact Information
Primary Industry
Drug Discovery
Stock Exchange
SHE
Primary Office
- Hite Science and Technology Park
- Wuhan Economic Development Zone
- Wuhan, Hubei 430056
- China
+86 027 0000 0000
Wuhan Hiteck Biological Stock Performance
(As of Tuesday closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.30 | $7.07 | $3.84 - $12.13 | $754M | 103M | 5.75M | $0.05 |
Wuhan Hiteck Biological Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 607,545 | 281,912 | 297,193 | 778,425 |
| Revenue | 75,880 | 89,763 | 89,319 | 111,019 |
| EBITDA | 3,872 | 12,199 | 16,934 | 24,660 |
| Net Income | 5,374 | 9,124 | 14,230 | 21,070 |
| Total Assets | 305,484 | 310,072 | 313,324 | 292,364 |
| Total Debt | 1,406 | 26,479 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Wuhan Hiteck Biological Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Wuhan Hiteck Biological‘s full profile, request access.
Request a free trialReady to get started?
Request a free trial